Key result
Complex decongestive physiotherapy remains the primary effective treatment for lymphatic vascular disease over drugs and surgery.
Why the study?
Lymphatic vascular disease diagnosis and management lack standardized pharmacological and surgical treatments, with reliance on physical examination and physiotherapy.
Complex decongestive physiotherapy remains the state-of-the-art therapeutic approach for lymphatic vascular disease, while pharmacological and surgical approaches have limited success.
Limits proven therapies for lymphatic vascular disease to complex decongestive physiotherapy; leaves open research into molecular treatments.
The lymphatic vasculature is comprised of a network of vessels that is essential both to fluid homeostasis and to the mediation of regional immune responses. In health, the lymphatic vasculature possesses the requisite transport capacity to accommodate the fluid load placed upon it. The most readily recognizable attribute of lymphatic vascular incompetence is the presence of the characteristic swelling of tissues, called lymphedema, which arises as a consequence of insufficient lymph transport. The diagnosis of lymphatic vascular disease relies heavily upon the physical examination. If the diagnosis remains in question, the presence of lymphatic vascular insufficiency can be ascertained through imaging, including indirect radionuclide lymphoscintigraphy. Beyond lymphoscintigraphy, clinically-relevant imaging modalities include magnetic resonance imaging and computerized axial tomography. The state-of-the-art therapeutic approach to lymphatic edema relies upon physiotherapeutic techniques. Complex decongestive physiotherapy is an empirically-derived, effective, multicomponent technique designed to reduce limb volume and maintain the health of the skin and supporting structures. The application of pharmacological therapies has been notably absent from the management strategies for lymphatic vascular insufficiency states. In general, drug-based approaches have been controversial at best. Surgical approaches to improve lymphatic flow through vascular reanastomosis have been, in large part, unsuccessful, but controlled liposuction affords lasting benefit in selected patients. In the future, specifically engineered molecular therapeutics may be designed to facilitate the controlled regrowth of damaged, dysfunctional, or obliterated lymphatic vasculature in order to circumvent or mitigate the vascular insufficiency that leads to edema and tissue destruction.
No takes yet. Share an insight, caveat, or question.
Stanley G. Rockson (2008) conducted a review in Lymphatic vascular disease. Complex decongestive physiotherapy remains the primary effective treatment for lymphatic vascular disease, while pharmacological and surgical approaches have largely been unsuccessful.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: